Xtx Topco LTD Sarepta Therapeutics, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$113.33 - $163.85 $518,824 - $750,105	4,578 New	4,578 $723,000
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $157,559 - $225,597	-2,495 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $192,813 - $248,052	2,495 New	2,495 $225,000
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $599,651 - $749,780	-8,643 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $624,456 - $1.46 Million	8,643 New	8,643 $644,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.74B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.